{"denomUnitsSelected":"Participants","reportingStatus":"NOT_POSTED","timeFrame":"Baseline to study completion (approximately 6 months)","title":"Number of Subjects With Adverse Drug Reactions and Toxicities as Evaluated by NCI CTCAE v4.03 as DKN-01 as Monotherapy or in Combination With Paclitaxel in Patients With Recurrent EEC or EOC or Carcinosarcoma (MMMT)","type":"OTHER_PRE_SPECIFIED"}